PE T/CT improves radiotherapy targeting for recurrent prostate cancer
A recently published article has demonstrated that the PET radiotracer 18F-fluciclovine can help guide and monitor targeted treatment for recurrent prostate cancer, allowing for individualized, targeted therapy.